Board Meetings for GLAXO
Detailed list of historic and upcoming board meetings.
| Symbol | Company | Meeting Date | Purpose | Description | Links |
|---|---|---|---|---|---|
| GLAXO | GlaxoSmithKline Pharmaceuticals Limited | 22 Oct 2018 | Financial Results | To consider and approve Un-Audited Financial Results for the Quarter and Half Year ended 30th September 2018 | |
| GLAXO | GlaxoSmithKline Pharmaceuticals Limited | 24 Jul 2018 | Financial Results | To consider and approve the financial results for the period ended Jun 30, 2018 | |
| GLAXO | GlaxoSmithKline Pharmaceuticals Limited | 24 May 2018 | Financial Results/Dividend/Other business matters | To consider and approve the financial results for the period ended March 31, 2018,to recommend dividend, if any on the equity shares of the Company and other business matters | |
| GLAXO | GlaxoSmithKline Pharmaceuticals Limited | 02 Feb 2018 | Results | inter-alia, to consider and approve Un-Audited Financial Results for the third quarter and nine months ended December 31, 2017. | |
| GLAXO | GlaxoSmithKline Pharmaceuticals Limited | 25 Oct 2017 | Results | inter-alia, to consider and approve Un-Audited Financial Results for the second quarter and half year ended September 30, 2017. | |
| GLAXO | GlaxoSmithKline Pharmaceuticals Limited | 25 Jul 2017 | Results | Approval and declaration of Un-Audited Financial Results for the quarter ended June 30, 2017. | |
| GLAXO | GlaxoSmithKline Pharmaceuticals Limited | 19 May 2017 | Results/Dividend | inter-alia, to consider amongst other things, approval of audited financial results (Standalone & Consolidated) for the quarter / year ended March 31,2017 and to recommend dividend, if any, on the equity shares of the Company. | |
| GLAXO | GlaxoSmithKline Pharmaceuticals Limited | 11 Feb 2017 | Results | Inter-alia, to consider and approve Un-Audited Financial Results for the quarter and nine months ended December 31, 2016. | |
| GLAXO | GlaxoSmithKline Pharmaceuticals Limited | 27 Oct 2016 | Results | Inter-alia, to consider and approve Un-Audited Financial Results for the quarter and half year ended September 30, 2016. | |
| GLAXO | GlaxoSmithKline Pharmaceuticals Limited | 28 Jul 2016 | Results | inter-alia, to consider and approve Un-Audited Financial Results for the first quarter ended June 30, 2016. | |
| GLAXO | GlaxoSmithKline Pharmaceuticals Limited | 25 May 2016 | Results/Dividend | inter-alia, to consider amongst other things, approval of audited financial results (Standalone & Consolidated) for the quarter / year ended March 31, 2016 and to recommend dividend, if any, on the equity shares of the Company. | |
| GLAXO | GlaxoSmithKline Pharmaceuticals Limited | 10 Feb 2016 | Results | inter-alia, to consider and approve Unaudited Financial Results of the Company for the quarter ended December 31, 2015. | |
| GLAXO | GlaxoSmithKline Pharmaceuticals Limited | 31 Oct 2015 | Results | To consider and approve the unaudited financial results for the quarter ended September 30, 2015. | |
| GLAXO | GlaxoSmithKline Pharmaceuticals Limited | 31 Jul 2015 | Results | Inter-alia , to consider and approve the Unaudited Financial Results for the quarter ended June 30, 2015. | |
| GLAXO | GlaxoSmithKline Pharmaceuticals Limited | 18 May 2015 | Results/Dividend | Inter-alia, to consider amongst other things, approval of audited financial results for the fifteen months period ended March 31, 2015 and to recommend dividend, if any, on the equity shares of the Company. |